|
2023
|
Invention
|
Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and prepa... |
|
2022
|
Invention
|
A vaccine for coronavirus and influenza virus, and method for preparation thereof.
The invention... |
|
|
Invention
|
A vaccine for coronavirus and influenza virus, and method for preparation thereof. The invention ... |
|
|
P/S
|
Vaccine for human use. |
|
|
Invention
|
Synergism of immunogenicity via combined parenteral and mucosal immunization against covid-19.
T... |
|
|
Invention
|
Synergism of immunogenicity via combined parental and mucosal immunization against covid-19. The ... |
|
|
Invention
|
Buffer free, acid stable low dose volume rotavirus vaccine.
A buffer free, acid stable, low dose... |
|
|
P/S
|
Vaccines for human use. |
|
|
P/S
|
Pharmaceutical preparations, namely, vaccines, not for veterinary use; pharmaceutical preparation... |
|
|
Invention
|
Adjuvanted inactivated recombinant rabies virus vectored coronavirus vaccine formulations.
The i... |
|
|
Invention
|
Adjuvanted inactivated recombinant rabies virus vectored coronavirus vaccine formulations. The in... |
|
2021
|
Invention
|
Stable formulations of low abundance enteroviruses vaccines and process of manufacture thereof. i... |
|
|
Invention
|
Novel agonist vaccine formulation.
The invention relates to novel agonist vaccine formulation, w... |
|
|
Invention
|
Toll-like receptor (tlr) agonist vaccine formulation. The invention relates to novel agonist vacc... |
|
|
Invention
|
Coronavirus vaccine and method for preparation thereof.
The present invention relates to vaccine... |
|
|
Invention
|
Coronavirus vaccine and method for preparation thereof. The present invention relates to vaccine ... |
|
|
P/S
|
Vaccine for human use |
|
|
Invention
|
Muramyl peptide derivatives. The invention is directed to Muramyl Dipeptide (MDP) derivative comp... |
|
|
Invention
|
Coronavirus vaccine through nasal immunization.
The invention generally discloses coronavirus va... |
|
|
Invention
|
Coronavirus vaccine through nasal immunization. The invention generally discloses coronavirus vac... |
|
|
P/S
|
Vaccine for human use |
|
|
P/S
|
Vaccine for human use. |
|
|
P/S
|
Vaccines for human use in treating and reducing the risk of contagious diseases caused by coronav... |
|
|
P/S
|
Vaccines and pharmaceutical preparations. |
|
|
Invention
|
Viral vaccine compositions and methods of preparations thereof.
The present invention relates to... |
|
|
Invention
|
Viral vaccine compositions and methods of preparations thereof. The present invention relates to ... |
|
2020
|
Invention
|
Vaccine compositions. The present disclosure provides vaccine compositions for prophylaxis and tr... |
|
2019
|
Invention
|
Adaptation of enterovirus to vero cells and vaccine formulations thereof.
Provided is an Enterov... |
|
|
Invention
|
Adaptation of enterovirus to vero cells and vaccine formulations thereof. The present invention d... |
|
|
Invention
|
A chimeric therapeutic vaccine. Disclosed are recombinant chimeric proteins of human epidermal gr... |
|
|
Invention
|
Multivalent glycoconjugates immunogenic compositions.
Provided are multivalent conjugate composi... |
|
|
Invention
|
Multivalent glycoconjugates immunogenic compositions. Disclosed are multivalent conjugate composi... |
|
|
Invention
|
Process for enterovirus purification and inactivation and vaccine compositions obtained thereof. ... |
|
|
Invention
|
A process for enterovirus purification and inactivation and vaccine compositions obtained thereof... |
|
2018
|
Invention
|
Salmonella infections. Salmonella typhi. The methods disclosed in this invention and the resultin... |
|
|
Invention
|
Synthetic polypeptide epitope based vaccine composition. Conserved epitopes selected from EV71 an... |
|
|
Invention
|
A synthetic polypeptide epitope based vaccine composition. Conserved epitopes selected from EV71 ... |
|
2017
|
P/S
|
Vaccines. |
|
|
P/S
|
Vaccine formulations |
|
|
Invention
|
Buffer free, acid stable low dose volume rotavirus vaccine. A buffer free, acid stable, low dose ... |
|
|
Invention
|
A buffer free, acid stable low dose volume rotavirus vaccine. A buffer free, acid stable, low dos... |
|
2016
|
Invention
|
Novel muramyl peptide derivative compound, synthesis and uses thereof. The invention relates to n... |
|
|
Invention
|
Muramyl peptide derivative compound, synthesis and uses thereof. The invention relates to novel M... |
|
|
Invention
|
Polysaccharide vaccine formulations and processes for industrial production of bacterial polysacc... |
|
2014
|
Invention
|
A viral vaccine and methods of manufacture thereof. The invention provides novel processes and ap... |
|
|
Invention
|
Bacterial vaccine and methods for manufacture thereof. Salmonella typhi. The methods disclosed in... |
|
|
Invention
|
A bacterial vaccine and methods for manufacture thereof. Disclosed are stable conjugate vaccine f... |
|
2013
|
Invention
|
Vaccine combinations. Vaccine combinations which comprise at least two or more of the following a... |
|
|
Invention
|
Rotavirus vaccine compositions and process for preparing the same. Invention provides novel rotav... |
|
2012
|
Invention
|
Inactivated chikungunya viruses (chikv) comprising an e1-k211e mutation. Aedis aegypti. |
